How does the Mounjaro pen work?

Each KwikPen holds four doses — one injection per week, same day each week, from the same pen.
Tirzepatide works on two gut-hormone receptors (GIP and GLP-1), making it the only dual-agonist weight-loss medicine currently licensed in the UK.
Injection sites are the abdomen, outer thigh, or upper arm, rotate the spot with each dose to avoid site reactions.
Treatment starts at 2.5 mg so your body has time to adjust, and your prescriber steps the dose up from there based on how you're getting on.

The Mounjaro pen is a pre-filled, once-weekly injection device that delivers tirzepatide just beneath the skin. Each KwikPen contains four weekly doses — you dial, press, and remove. The medicine then activates both GIP and GLP-1 receptors in the body, reducing appetite and slowing how quickly food leaves the stomach. As a prescription-only medicine, a prescriber assesses your suitability before treatment starts. See the full Mounjaro injection overview for the broader picture on how tirzepatide is used for weight management in the UK.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using the Mounjaro KwikPen, what actually happens at each step

What does the Mounjaro pen physically do when you press it?

The Mounjaro KwikPen is a multi-dose, pre-filled auto-injector. Eli Lilly designed it so that the needle inserts and the dose delivers in a single button-press, you don't have to draw up any medicine or handle a syringe. The pen holds enough tirzepatide for four weekly injections, and you move a dose indicator forward each time. Before you inject, you clean the chosen site with an alcohol swab, pinch the skin gently, hold the pen flat against it, and press until the dose window confirms delivery. The needle retracts automatically once you lift the pen away.

One habit worth building before your first injection: check the liquid in the pen window. It should be clear to slightly yellow and free of particles. This takes under thirty seconds and confirms the pen hasn't been damaged or frozen. If it looks cloudy or contains visible specks, don't use it, contact your prescriber or our team via our support page.

The pen should be stored in the fridge between 2 °C and 8 °C. There is a limited window during which it can be kept at room temperature, but the exact duration is set out in the Patient Information Leaflet rather than here, that's always your definitive reference. Our guide to Mounjaro shelf life covers storage in practical detail.

How does tirzepatide actually reduce appetite after injection?

Once tirzepatide enters the bloodstream it binds to two receptors: the GIP receptor and the GLP-1 receptor. Both are involved in regulating how the body responds to eating. GLP-1 receptor agonists were the first class of weight-loss injections, and tirzepatide adds GIP activation on top, a combination not available in any other UK-licensed weight-loss medicine. More on the weight-loss mechanism is covered separately if you want the deeper biology.

The practical result: food stays in the stomach longer, so the feeling of fullness comes sooner and lasts longer. Signals in the brain's appetite centres are dampened, so hunger between meals falls. Most people notice this effect building over the first few weeks as the dose increases, the 2.5 mg starting dose is calibrated for tolerability rather than maximum effect. How long after injecting Mounjaro you notice results is a question we've answered in full, because it varies more than the packaging suggests.

The NHS medicines page on tirzepatide explains the mechanism in patient-level language and is worth a read alongside the leaflet that comes with your pen (NHS: tirzepatide).

What side effects come with how the pen works, and when should you get help?

Most side effects from Mounjaro trace back to what tirzepatide does to the digestive system. Nausea, loose stools, constipation, indigestion, and burping are the most commonly reported, especially after starting or stepping up the dose. They tend to be most noticeable in the first few days of each new dose level and ease as the body adjusts.

Injection-site reactions (mild redness, itching, or a small lump where you injected) are also possible. Rotating sites between the abdomen, outer thigh, and upper arm reduces the chance of these building up. Pre-injection swabs keep the site clean and can reduce localised irritation.

More serious, and worth knowing clearly: in January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent side effect of GLP-1 class medicines. The symptom to act on is severe, persistent stomach pain that spreads to the back, with or without vomiting. That warrants urgent medical attention, call 999 or go to A&E rather than waiting for a GP appointment. You can also report any suspected side effects directly through the MHRA Yellow Card scheme.

Pregnancy, breastfeeding, and actively trying to conceive are situations where Mounjaro is not recommended. It is not licensed for anyone under 18. If your medical picture changes (new diagnosis, new medication, planned surgery) tell your prescriber before your next dose.

Does changing the injection site or timing affect how the pen works?

Rotating injection sites matters more than many people realise. Injecting repeatedly into the same spot causes a build-up of scar tissue under the skin, which slows absorption and makes results less predictable. The approved sites are the abdomen (at least a few centimetres from the navel), the outer thigh, and the upper arm. A simple pattern (abdomen this week, thigh next, upper arm the week after) removes any guesswork.

Timing relative to food doesn't affect Mounjaro's absorption the way it does with some oral medicines. The injection can be given at any time of day and doesn't need to be tied to a meal. What does matter is consistency: the same day of the week, give or take a day if you need flexibility, keeps tirzepatide levels steadier in the bloodstream. How soon the injection takes effect depends partly on this consistency building up over weeks.

If you're thinking about where Mounjaro fits within your options or how the clinical process works before a pen arrives, our weight-loss treatment overview sets that out plainly. And for anyone weighing up costs and what a private prescription actually includes, our guide to buying Mounjaro online covers the landscape. Starting treatment always follows a clinical assessment, a free consultation with our prescribers is the first step if you'd like to explore whether it's right for you.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions